Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
Market Analysis and Insights: Global Drug Delivery Devices Market
The global Drug Delivery Devices market is projected to grow from US$ 43590 million in 2024 to US$ 58080 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.9% during the forecast period.
The top five global manufacturers of drug delivery equipment are Cipla, Baxter International, Nipro Corporation, Roche and Boehringer Ingelheim, with a combined market share of 29 per cent. North America, which has a well-established healthcare infrastructure and a large number of leading pharmaceutical and biopharmaceutical companies (around 80% of the world's research and development in biopharmaceutical is conducted by US-based firms), is the largest market for drug delivery, about for 47% followed by Europe with 28%.
Report Covers:
This report presents an overview of global market for Drug Delivery Devices market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drug Delivery Devices, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drug Delivery Devices, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug Delivery Devices revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Drug Delivery Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Drug Delivery Devices revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Cipla
Baxter International
Nipro Corporation
Roche
Boehringer Ingelheim
Allergan
3M
BD
Catalent
Valeant Pharmaceuticals
Bayer AG
Chiesi
Phillips-Medisize
Johnson & Johnson
Shandong Weigao
Pfizer
B.Braun
Novartis AG
Zhengkang
Gerresheimer
COVIDIEN Medtronic
Schott forma vitrum
Alkermes
Skyepharma
Segment by Type
Injection Type
Mucosal Type
Implanted Type
Others Type
Segment by Application
Pharmaceutical Companies
Hospitals
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Drug Delivery Devices in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Delivery Devices companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Delivery Devices revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Delivery Devices Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Injection Type
1.2.3 Mucosal Type
1.2.4 Implanted Type
1.2.5 Others Type
1.3 Market by Application
1.3.1 Global Drug Delivery Devices Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Hospitals
1.3.4 Clinics
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Delivery Devices Market Perspective (2019-2030)
2.2 Global Drug Delivery Devices Growth Trends by Region
2.2.1 Drug Delivery Devices Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Delivery Devices Historic Market Size by Region (2019-2024)
2.2.3 Drug Delivery Devices Forecasted Market Size by Region (2025-2030)
2.3 Drug Delivery Devices Market Dynamics
2.3.1 Drug Delivery Devices Industry Trends
2.3.2 Drug Delivery Devices Market Drivers
2.3.3 Drug Delivery Devices Market Challenges
2.3.4 Drug Delivery Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Drug Delivery Devices by Players
3.1.1 Global Drug Delivery Devices Revenue by Players (2019-2024)
3.1.2 Global Drug Delivery Devices Revenue Market Share by Players (2019-2024)
3.2 Global Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drug Delivery Devices, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Drug Delivery Devices Market Concentration Ratio
3.4.1 Global Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Delivery Devices Revenue in 2023
3.5 Global Key Players of Drug Delivery Devices Head office and Area Served
3.6 Global Key Players of Drug Delivery Devices, Product and Application
3.7 Global Key Players of Drug Delivery Devices, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Delivery Devices Breakdown Data by Type
4.1 Global Drug Delivery Devices Historic Market Size by Type (2019-2024)
4.2 Global Drug Delivery Devices Forecasted Market Size by Type (2025-2030)
5 Drug Delivery Devices Breakdown Data by Application
5.1 Global Drug Delivery Devices Historic Market Size by Application (2019-2024)
5.2 Global Drug Delivery Devices Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Delivery Devices Market Size (2019-2030)
6.2 North America Drug Delivery Devices Market Size by Type
6.2.1 North America Drug Delivery Devices Market Size by Type (2019-2024)
6.2.2 North America Drug Delivery Devices Market Size by Type (2025-2030)
6.2.3 North America Drug Delivery Devices Market Share by Type (2019-2030)
6.3 North America Drug Delivery Devices Market Size by Application
6.3.1 North America Drug Delivery Devices Market Size by Application (2019-2024)
6.3.2 North America Drug Delivery Devices Market Size by Application (2025-2030)
6.3.3 North America Drug Delivery Devices Market Share by Application (2019-2030)
6.4 North America Drug Delivery Devices Market Size by Country
6.4.1 North America Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Drug Delivery Devices Market Size by Country (2019-2024)
6.4.3 North America Drug Delivery Devices Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Drug Delivery Devices Market Size (2019-2030)
7.2 Europe Drug Delivery Devices Market Size by Type
7.2.1 Europe Drug Delivery Devices Market Size by Type (2019-2024)
7.2.2 Europe Drug Delivery Devices Market Size by Type (2025-2030)
7.2.3 Europe Drug Delivery Devices Market Share by Type (2019-2030)
7.3 Europe Drug Delivery Devices Market Size by Application
7.3.1 Europe Drug Delivery Devices Market Size by Application (2019-2024)
7.3.2 Europe Drug Delivery Devices Market Size by Application (2025-2030)
7.3.3 Europe Drug Delivery Devices Market Share by Application (2019-2030)
7.4 Europe Drug Delivery Devices Market Size by Country
7.4.1 Europe Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Drug Delivery Devices Market Size by Country (2019-2024)
7.4.3 Europe Drug Delivery Devices Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Drug Delivery Devices Market Size (2019-2030)
8.2 China Drug Delivery Devices Market Size by Type
8.2.1 China Drug Delivery Devices Market Size by Type (2019-2024)
8.2.2 China Drug Delivery Devices Market Size by Type (2025-2030)
8.2.3 China Drug Delivery Devices Market Share by Type (2019-2030)
8.3 China Drug Delivery Devices Market Size by Application
8.3.1 China Drug Delivery Devices Market Size by Application (2019-2024)
8.3.2 China Drug Delivery Devices Market Size by Application (2025-2030)
8.3.3 China Drug Delivery Devices Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Drug Delivery Devices Market Size (2019-2030)
9.2 Asia Drug Delivery Devices Market Size by Type
9.2.1 Asia Drug Delivery Devices Market Size by Type (2019-2024)
9.2.2 Asia Drug Delivery Devices Market Size by Type (2025-2030)
9.2.3 Asia Drug Delivery Devices Market Share by Type (2019-2030)
9.3 Asia Drug Delivery Devices Market Size by Application
9.3.1 Asia Drug Delivery Devices Market Size by Application (2019-2024)
9.3.2 Asia Drug Delivery Devices Market Size by Application (2025-2030)
9.3.3 Asia Drug Delivery Devices Market Share by Application (2019-2030)
9.4 Asia Drug Delivery Devices Market Size by Region
9.4.1 Asia Drug Delivery Devices Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Drug Delivery Devices Market Size by Region (2019-2024)
9.4.3 Asia Drug Delivery Devices Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Drug Delivery Devices Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Drug Delivery Devices Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drug Delivery Devices Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Drug Delivery Devices Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Drug Delivery Devices Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Drug Delivery Devices Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drug Delivery Devices Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Drug Delivery Devices Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Drug Delivery Devices Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Drug Delivery Devices Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Drug Delivery Devices Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Drug Delivery Devices Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Cipla
11.1.1 Cipla Company Details
11.1.2 Cipla Business Overview
11.1.3 Cipla Drug Delivery Devices Introduction
11.1.4 Cipla Revenue in Drug Delivery Devices Business (2019-2024)
11.1.5 Cipla Recent Developments
11.2 Baxter International
11.2.1 Baxter International Company Details
11.2.2 Baxter International Business Overview
11.2.3 Baxter International Drug Delivery Devices Introduction
11.2.4 Baxter International Revenue in Drug Delivery Devices Business (2019-2024)
11.2.5 Baxter International Recent Developments
11.3 Nipro Corporation
11.3.1 Nipro Corporation Company Details
11.3.2 Nipro Corporation Business Overview
11.3.3 Nipro Corporation Drug Delivery Devices Introduction
11.3.4 Nipro Corporation Revenue in Drug Delivery Devices Business (2019-2024)
11.3.5 Nipro Corporation Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Drug Delivery Devices Introduction
11.4.4 Roche Revenue in Drug Delivery Devices Business (2019-2024)
11.4.5 Roche Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Drug Delivery Devices Introduction
11.5.4 Boehringer Ingelheim Revenue in Drug Delivery Devices Business (2019-2024)
11.5.5 Boehringer Ingelheim Recent Developments
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview
11.6.3 Allergan Drug Delivery Devices Introduction
11.6.4 Allergan Revenue in Drug Delivery Devices Business (2019-2024)
11.6.5 Allergan Recent Developments
11.7 3M
11.7.1 3M Company Details
11.7.2 3M Business Overview
11.7.3 3M Drug Delivery Devices Introduction
11.7.4 3M Revenue in Drug Delivery Devices Business (2019-2024)
11.7.5 3M Recent Developments
11.8 BD
11.8.1 BD Company Details
11.8.2 BD Business Overview
11.8.3 BD Drug Delivery Devices Introduction
11.8.4 BD Revenue in Drug Delivery Devices Business (2019-2024)
11.8.5 BD Recent Developments
11.9 Catalent
11.9.1 Catalent Company Details
11.9.2 Catalent Business Overview
11.9.3 Catalent Drug Delivery Devices Introduction
11.9.4 Catalent Revenue in Drug Delivery Devices Business (2019-2024)
11.9.5 Catalent Recent Developments
11.10 Valeant Pharmaceuticals
11.10.1 Valeant Pharmaceuticals Company Details
11.10.2 Valeant Pharmaceuticals Business Overview
11.10.3 Valeant Pharmaceuticals Drug Delivery Devices Introduction
11.10.4 Valeant Pharmaceuticals Revenue in Drug Delivery Devices Business (2019-2024)
11.10.5 Valeant Pharmaceuticals Recent Developments
11.11 Bayer AG
11.11.1 Bayer AG Company Details
11.11.2 Bayer AG Business Overview
11.11.3 Bayer AG Drug Delivery Devices Introduction
11.11.4 Bayer AG Revenue in Drug Delivery Devices Business (2019-2024)
11.11.5 Bayer AG Recent Developments
11.12 Chiesi
11.12.1 Chiesi Company Details
11.12.2 Chiesi Business Overview
11.12.3 Chiesi Drug Delivery Devices Introduction
11.12.4 Chiesi Revenue in Drug Delivery Devices Business (2019-2024)
11.12.5 Chiesi Recent Developments
11.13 Phillips-Medisize
11.13.1 Phillips-Medisize Company Details
11.13.2 Phillips-Medisize Business Overview
11.13.3 Phillips-Medisize Drug Delivery Devices Introduction
11.13.4 Phillips-Medisize Revenue in Drug Delivery Devices Business (2019-2024)
11.13.5 Phillips-Medisize Recent Developments
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Details
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Drug Delivery Devices Introduction
11.14.4 Johnson & Johnson Revenue in Drug Delivery Devices Business (2019-2024)
11.14.5 Johnson & Johnson Recent Developments
11.15 Shandong Weigao
11.15.1 Shandong Weigao Company Details
11.15.2 Shandong Weigao Business Overview
11.15.3 Shandong Weigao Drug Delivery Devices Introduction
11.15.4 Shandong Weigao Revenue in Drug Delivery Devices Business (2019-2024)
11.15.5 Shandong Weigao Recent Developments
11.16 Pfizer
11.16.1 Pfizer Company Details
11.16.2 Pfizer Business Overview
11.16.3 Pfizer Drug Delivery Devices Introduction
11.16.4 Pfizer Revenue in Drug Delivery Devices Business (2019-2024)
11.16.5 Pfizer Recent Developments
11.17 B.Braun
11.17.1 B.Braun Company Details
11.17.2 B.Braun Business Overview
11.17.3 B.Braun Drug Delivery Devices Introduction
11.17.4 B.Braun Revenue in Drug Delivery Devices Business (2019-2024)
11.17.5 B.Braun Recent Developments
11.18 Novartis AG
11.18.1 Novartis AG Company Details
11.18.2 Novartis AG Business Overview
11.18.3 Novartis AG Drug Delivery Devices Introduction
11.18.4 Novartis AG Revenue in Drug Delivery Devices Business (2019-2024)
11.18.5 Novartis AG Recent Developments
11.19 Zhengkang
11.19.1 Zhengkang Company Details
11.19.2 Zhengkang Business Overview
11.19.3 Zhengkang Drug Delivery Devices Introduction
11.19.4 Zhengkang Revenue in Drug Delivery Devices Business (2019-2024)
11.19.5 Zhengkang Recent Developments
11.20 Gerresheimer
11.20.1 Gerresheimer Company Details
11.20.2 Gerresheimer Business Overview
11.20.3 Gerresheimer Drug Delivery Devices Introduction
11.20.4 Gerresheimer Revenue in Drug Delivery Devices Business (2019-2024)
11.20.5 Gerresheimer Recent Developments
11.21 COVIDIEN Medtronic
11.21.1 COVIDIEN Medtronic Company Details
11.21.2 COVIDIEN Medtronic Business Overview
11.21.3 COVIDIEN Medtronic Drug Delivery Devices Introduction
11.21.4 COVIDIEN Medtronic Revenue in Drug Delivery Devices Business (2019-2024)
11.21.5 COVIDIEN Medtronic Recent Developments
11.22 Schott forma vitrum
11.22.1 Schott forma vitrum Company Details
11.22.2 Schott forma vitrum Business Overview
11.22.3 Schott forma vitrum Drug Delivery Devices Introduction
11.22.4 Schott forma vitrum Revenue in Drug Delivery Devices Business (2019-2024)
11.22.5 Schott forma vitrum Recent Developments
11.23 Alkermes
11.23.1 Alkermes Company Details
11.23.2 Alkermes Business Overview
11.23.3 Alkermes Drug Delivery Devices Introduction
11.23.4 Alkermes Revenue in Drug Delivery Devices Business (2019-2024)
11.23.5 Alkermes Recent Developments
11.24 Skyepharma
11.24.1 Skyepharma Company Details
11.24.2 Skyepharma Business Overview
11.24.3 Skyepharma Drug Delivery Devices Introduction
11.24.4 Skyepharma Revenue in Drug Delivery Devices Business (2019-2024)
11.24.5 Skyepharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Cipla
Baxter International
Nipro Corporation
Roche
Boehringer Ingelheim
Allergan
3M
BD
Catalent
Valeant Pharmaceuticals
Bayer AG
Chiesi
Phillips-Medisize
Johnson & Johnson
Shandong Weigao
Pfizer
B.Braun
Novartis AG
Zhengkang
Gerresheimer
COVIDIEN Medtronic
Schott forma vitrum
Alkermes
Skyepharma
听
听
*If Applicable.
